Escitalopram oxalate: Co-existence of oxalate dianions and oxalic acid mol-ecules in the same crystal

Acta Crystallographica Section C: Crystal Structure Communications

Volumn 63, Issue 2, 2007, Pages

  Harrison, William T A ^a   Yathirajan, H S ^b   Bindya, S ^b   Anilkumar, H G ^b   Devaraju, ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF MYSORE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CRYSTAL STRUCTURE; HYDROGEN BONDS; SUPRAMOLECULAR CHEMISTRY;

ESCITALOPRAM CATION; OXALATE DIANIONS; OXALIC ACID;

ORGANIC COMPOUNDS;

EID: 33846945738     PISSN: 01082701     EISSN: 01082701     Source Type: Journal    
DOI: 10.1107/S010827010605520X     Document Type: Article

References (14)

1. Allen, F. H. (2002). Acta Cryst. B58, 380-388.
2. Blessing, R. H. (1995). Acta Cryst. A51, 33-38.
3. Bruker (2003). SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
4. Burke, W. J. (2002). Expert Opin. Invest. Drugs, 11, 1477-1486.
5. Chaix-Pluchery, O., Mutin, J. C., Bouillot, J. & Niepce, J. C. (1989). Acta Cryst. C45, 1699-1705.
6. Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.
7. Harrison, W. T. A., Yathirajan, H. S., Anilkumar, H. G., Sarojini, B. K., Narayana, B. & Lobo, K. G. (2005). Acta Cryst. E61, o3810-o3812.
8. Newkome, G. R., Theriot, K. J. & Fronczek, F. R. (1985). Acta Cryst. C41, 1642-1644.
9. Nonius (1998). COLLECT. Nonius BV, Delft, The Netherlands.
10. Otwinowski, Z. & Minor, W. (1997). Methods in Enzymology, Vol. 276, Macromolecular Crystallography, Part A, edited by C. W. Carter Jr & R. M. Sweet, pp. 307-326. New York: Academic Press.
11. Periasamy, M., Reddy, M. N. & Anwar, S. (2004). Tetrahedron Asymmetry, 15, 1809-1812.
12. Sanchez, C., Bogeso, K. P., Ebert, B., Reines, E. H. & Braestrup, C. (2004). Psychopharmacology, 174, 163-176.
13. Sheldrick, G. M. (1997). SHELXS97 and SHELXL97. University of Göttingen, Germany.
14. Sorbera, L. A., Revel, L., Martin, L. & Castaner, J. (2001). Drugs Future, 26, 115-120.